40 results on '"Tamburrino, Anna"'
Search Results
2. Supplementary Figure 1 from Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases
3. Supplementary Tables 1-3 from Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases
4. Data from CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
5. Supplementary Figure 3 from CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
6. Supplementary Figure 1 from CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
7. Supplementary Figure 2 from CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
8. Supplementary Figure Legends 1-5 from CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
9. Supplementary Figure 4 from CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
10. Supplementary Figure 5 from CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
11. Supplementary Methods from CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
12. Rationale and clinical use of multitargeting anticancer agents
13. Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma
14. Targeting α-Synuclein: Therapeutic Options
15. Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells
16. Functional Characterization of the Novel T599I-VKSRdel BRAF Mutation in a Follicular Variant Papillary Thyroid Carcinoma
17. Additional file 2: of Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinsonâ s disease
18. Cartella sanitaria e di rischio (D.Lgs 81/2008) e documento sanitario personale (D.Lgs 230/95): raffronto critico
19. La ricerca universitaria in Medicina del Lavoro in Italia dal 1998 al 2007
20. Aged and Diseased Neurons Get Lost in Transport
21. Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment
22. Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson’s disease
23. Anti-VEGF Treatment-Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype
24. TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance
25. Abstract 3605: Combined inhibition of IL-1, CXCR1/2, and TGFβ signaling pathways modulates in vivo acquired resistance to anti-VEGF treatment
26. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis
27. RET-mediated CD44 proteolysis promotes autonomous proliferation of thyroid cells
28. Toll-Like Receptor 9 Agonists for Cancer Therapy
29. Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
30. Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases
31. CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells
32. Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors inBRAFMutant Thyroid Carcinoma Cells
33. Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells
34. Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif
35. Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells.
36. Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia
37. The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells
38. Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells
39. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
40. The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.